Abstract
Objective
This study aimed to translate and cross-culturally adapt the Niigata Persistent Postural-Perceptual Dizziness Questionnaire (NPQ) into Turkish and evaluate its psychometric properties, including reliability, validity, and diagnostic accuracy, in Turkish-speaking patients with Persistent Postural-Perceptual Dizziness (PPPD).
Methods
This prospective case-control study included 114 participants: 36 PPPD patients, 40 with other vestibular disorders, and 38 healthy controls. Participants completed the Turkish version of the NPQ (T-NPQ) and the Dizziness Handicap Inventory (DHI). Internal consistency was assessed using Cronbach’s alpha, and test-retest reliability was evaluated over 14–30-day interval. Construct validity was tested through confirmatory factor analysis (CFA) to test the hypothesized three-factor structure (Upright Posture/Walking, Movement, and Visual Stimulation), while convergent validity was examined by correlating T-NPQ scores with DHI scores. Diagnostic accuracy was assessed using Receiver Operating Characteristic (ROC) curve analysis.
Results
The T-NPQ demonstrated excellent internal consistency (Cronbach’s α = 0.919) and strong test-retest reliability (r = 0.832, p < .001). CFA supported the hypothesized three-factor structure and showed good model fit (χ2/df = 1.47, CFI = 0.964, RMSEA = 0.064). T-NPQ total scores strongly correlated with DHI total scores (r = 0.709, p < .001). The T-NPQ discriminated PPPD patients from other vestibular patients with an Area Under the Curve (AUC) of 0.746. The optimal cut-off score of 27.5 showed sensitivity of 86.1% and specificity of 57.5%.
Conclusion
The Turkish version of the NPQ is a reliable and valid tool that may be useful for assessing symptom severity in PPPD patients. It has the potential to be effective for screening and measuring outcomes in clinical practice and research in Turkey.
Keywords
Introduction
Vestibular disorders, commonly presenting with vertigo, dizziness, and postural imbalance, substantially impair daily functioning and overall quality of life. Persistent Postural-Perceptual Dizziness (PPPD) is a distinct clinical entity characterized by persistent dizziness, unsteadiness, or non-spinning vertigo arising from an interaction of sensory, perceptual, and psychological mechanisms that alter neural processes responsible for postural control and locomotion. 1 PPPD consolidates several previously used diagnostic labels including phobic postural vertigo, visual vertigo, space-motion discomfort, and chronic subjective dizziness into a unified diagnosis supported by standardized criteria. 2 According to the International Classification of Vestibular Disorders, PPPD symptoms persist for at least 3 months and are consistently exacerbated by upright posture, motion, and visually complex environments. 2
The diagnosis of PPPD remains challenging because it frequently coexists with other vestibular and psychological conditions. Accurate identification requires a detailed clinical history, targeted vestibular assessment, and the exclusion of alternative causes, often through multidisciplinary evaluation involving neurology, otolaryngology, and mental health specialists. 1 Despite its clinical relevance, PPPD is often diagnosed late, with delays extending several years in many patients.3–5 The condition is more common among females and individuals between 30 and 50 years old.5,6 The absence of objective biomarkers and the subjective nature of symptoms continue to complicate diagnostic accuracy.6–8
To improve diagnostic consistency and symptom characterization, recent research has focused on standardized assessment tools. The Niigata PPPD Questionnaire (NPQ), developed by Yagi et al. 9 based on the Bárány Society criteria, 2 is one of the leading instruments designed to capture PPPD-specific symptom patterns.2,9 It has demonstrated utility in distinguishing PPPD from other vestibular disorders, quantifying symptom severity, and identifying individuals at risk of developing PPPD following acute vestibular events.7,10,11 The NPQ has been translated and validated in Spanish- and German-speaking populations,5,12 yet no validated Turkish version has been available to date. Given the global prevalence of dizziness and the clinical importance of culturally adapted measurement tools, establishing such a version is essential. Considering the relatively high prevalence of dizziness and vestibular disorders in Turkey, and the potential benefits of having a validated tool to assess PPPD symptoms in Turkish, this adaptation could be valuable for enhancing clinical diagnosis and management in Turkish-speaking populations.
In clinical settings, the Dizziness Handicap Inventory (DHI), originally developed by Jacobson and Newman, is widely used to assess the functional, emotional, and physical impact of dizziness. 13 Although it effectively quantifies dizziness-related disability, the DHI does not distinguish PPPD from other vestibular conditions. Therefore, combining a PPPD-specific scale such as the NPQ with a general disability measure such as the DHI enables a more comprehensive assessment of symptom burden.
The aim of the present study was to translate and culturally adapt the NPQ into Turkish and evaluate its psychometric properties in PPPD patients, other vestibular patients, and healthy controls. In addition to NPQ scores, dizziness-related disability was assessed using the DHI, enabling comparisons between PPPD-specific symptoms and general dizziness handicap. Although selective serotonin reuptake inhibitors (SSRIs) are commonly used in the management of PPPD and have been discussed as potential confounders in symptom assessment by Yagi et al., 9 the present study did not include an analysis of medication effects. We hypothesized that PPPD patients would demonstrate higher NPQ and DHI scores compared with other groups.
Materials and methods
Design
An observational questionnaire validation study was conducted in accordance with the ethical principles of the Declaration of Helsinki and approved on 01/08/2024 by the Non-Interventional Clinical Research Ethics Committee of Istanbul Medipol University (Approval No: 744).
Participants
For the sample size calculation, the principle of using at least 10 subjects per item was applied, with a minimum of 80 participants recommended for validity studies. 14 Considering that the Niigata PPPD Questionnaire (NPQ) consists of 12 items, a target sample size of approximately 120 participants was determined.
Following the methodology of Yagi et al., 9 we aimed to validate the Turkish version of the NPQ in a sample similar to that of the original validation study. Accordingly, we initially sought to include 45 patients diagnosed with PPPD according to the diagnostic criteria of the Bárány Society, 2 40 patients with other vestibular disorders, and 38 healthy control participants, matched by age and sex to the patient groups, with no history of otoneurologic or psychiatric disorders. In this study, to account for potential confounders such as psychiatric and cognitive disorders, the Montreal Cognitive Assessment (MoCA) test was administered, and participants with a MoCA score of 26 or higher were included in the study.
Participants were recruited between September 2024 and December 2025 from three centers in Istanbul: Bagcilar Medipol Mega University Hospital, Asya ENT Clinic, and Umraniye Training and Research Hospital, representing a university hospital, a private specialty clinic, and a public research and training hospital.
Among the initially recruited PPPD patients, a total of nine individuals were excluded from the final dataset. This exclusion was based on the following criteria: three patients were removed due to incomplete questionnaire responses, which hindered the accurate assessment of their symptoms; two patients were reclassified after specialist evaluation, leading to the identification of alternative diagnoses that did not meet the criteria for PPPD; two patients did not complete the retest procedure, compromising the assessment of test-retest reliability; and two patients were excluded due to the identification of psychiatric or cognitive comorbidities, which could interfere with the validity of the questionnaire results. Consequently, the final analytical sample consisted of 36 PPPD patients, 40 patients with other vestibular disorders, and 38 healthy controls. The exclusion of patients with psychiatric or cognitive comorbidities, as well as incomplete responses or retest non-completion, ensured that the final analysis would focus on clinically stable and valid PPPD cases, reducing potential bias in the psychometric evaluation (Figure 1). Study participant flow chart. The diagram details the recruitment process for PPPD, Other Vestibular, and Healthy Control groups. Out of 45 participants allocated to the PPPD group, nine were excluded due to incomplete responses, reclassified diagnoses, incomplete retests, or comorbidities. Final analysis included 36 participants in the PPPD group, 40 in the Other Vestibular group, and 38 Healthy Controls.
The retest reliability analysis was performed with the same 36 PPPD participants, who completed the second administration of the Turkish NPQ 14–30 days after the initial assessment to ensure clinical stability and minimize recall bias.
All participants were informed about the study purpose and procedures, and written informed consent was obtained prior to data collection. The NPQ was administered both face-to-face and via Google Forms®, ensuring standardized data collection. All data were anonymized and coded using Microsoft Excel® for subsequent statistical analysis.
Translation and cultural adaptation
The translation and cross-cultural adaptation of the Niigata Persistent Postural-Perceptual Dizziness Questionnaire (NPQ) into Turkish were performed following internationally accepted guidelines for adapting patient-reported outcome measures. 14 The process aimed to ensure semantic, idiomatic, experiential, and conceptual equivalence between the original and Turkish versions while preserving clinical relevance for the Turkish-speaking population.
The adaptation procedure comprised four main stages. First, two independent bilingual translators one audiologist experienced in vestibular disease and rehabilitation and one professional translator without a medical background produced two forward translations from English into Turkish. Second, these versions were compared and synthesized by the research team into a single reconciled draft that reflected both linguistic accuracy and clinical clarity. Third, two native English speakers fluent in Turkish, who were blinded to the original NPQ, conducted independent back-translations into English to verify the consistency of meaning and identify potential conceptual discrepancies. Finally, an expert committee reviewed all translated versions to finalize the wording of each item.
The expert committee included six professionals: three audiologists with clinical experience in vestibular disease and rehabilitation, two linguists specializing in Turkish language and semantics, and one English language specialist. Each member evaluated the semantic and conceptual equivalence of the Turkish translation using a four-point relevance scale (1 = not relevant, 2 = somewhat relevant, 3 = quite relevant, 4 = highly relevant). The Item-level Content Validity Index (I-CVI) ranged from 0.83 to 1.00, while the Scale-level CVI (S-CVI/Ave) was 0.93, demonstrating excellent content validity according to Polit and Beck’s criteria (≥0.90). 15 Items 2, 6, 8, and 10 received slightly lower scores (I-CVI = 0.83), primarily due to linguistic nuances in Turkish related to visual and spatial descriptions and were refined through consensus to improve clarity without altering conceptual content.
The final Turkish version retained the original 12-item structure and six-point Likert-type response format, ranging from 0 (no difficulty) to 6 (severe difficulty/avoidance). The three original subscales described by Yagi et al.
9
were preserved to reflect distinct symptom dimensions: • Postural and gait disturbance – items 3, 6, 7, and 11, addressing balance maintenance, standing posture, and locomotor stability. • Motion sensitivity – items 1, 5, 9, and 12, assessing dizziness or imbalance induced by self-motion or passive movement (e.g., traveling by vehicle, elevator). • Visual dependence – items 2, 4, 8, and 10, reflecting sensitivity to complex visual motion, bright lights, or fast-moving scenes.
Each subscale has a maximum score of 24, and the total NPQ score ranges from 0 to 72, with higher scores indicating greater symptom severity and postural-perceptual impairment. The validated version was titled T-NPQ.
Dizziness Handicap Inventory (DHI)
DHI was used to evaluate the self-perceived disability associated with dizziness and imbalance among participants. 13 The DHI is a 25-item questionnaire divided into three subscales that assess the impact of dizziness on daily life: physical (7 items), emotional (9 items), and functional (9 items) domains. Each item is scored on a three-point Likert scale (yes = 4, sometimes = 2, no = 0), yielding a total score ranging from 0 to 100, with higher scores indicating greater self-perceived handicap due to dizziness.
The DHI has been widely used in clinical and research contexts for vestibular disorders and is considered a standard measure of dizziness-related functional impairment. Its Turkish version was adapted and validated by Canbal et al. (2016), demonstrating high internal consistency and test-retest reliability in patients with vestibular pathologies. 16
In this study, the DHI total and subscale scores were collected and used to examine the association between self-perceived dizziness-related disability and PPPD symptom severity. The DHI was also employed for the assessment of convergent validity, through correlation analyses with the total and subscale scores of the NPQ.
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics Version 27 and IBM SPSS AMOS. Descriptive statistics were calculated, including arithmetic means, standard deviations, and the range (minimum–maximum values). To assess scale validity, both language and content validity were thoroughly examined. The internal consistency of the scale was determined by calculating Cronbach’s alpha coefficients for each subscale and for the total scale.
The reliability of the scale was further evaluated through test-retest stability, based on item-level mean scores, standard deviations, and Pearson correlation coefficients. Subsequently, CFA was carried out using IBM SPSS AMOS to validate the hypothesized factor structure, with the significance level set at p < .05. Model fit was evaluated using χ2/df, the Comparative Fit Index (CFI), and the Root Mean Square Error of Approximation (RMSEA).
Results
Demographic and clinical characteristics of the PPPD, vestibular, and control groups.
Values are presented as Mean ± Standard Deviation or number (percentage). DHI: Dizziness Handicap Inventory; BPPV: Benign Paroxysmal Positional Vertigo.
aOne-way ANOVA.
bChi-square test (Sex).
cKruskal–Wallis test (DHI scores).
dChi-square test (comparison of diagnostic distribution between PPPD and Vestibular groups).
The DHI total and subscale scores differed significantly among the groups (p < .001). The PPPD group exhibited the highest DHI total scores (50.03 ± 10.32), followed by the vestibular group (41.43 ± 9.04), while the control group showed minimal scores. Regarding clinical history (Table 1), the most common precipitating condition for the PPPD group was Benign Paroxysmal Positional Vertigo (BPPV) (27.8%), followed by vestibular migraine (22.2%) and vestibular neuritis (16.7%). Similarly, BPPV was the most frequent primary diagnosis in the vestibular group (30.0%).
Internal consistency and test-retest reliability coefficients of the Turkish NPQ and its subscales.
Note. T1: Test (initial assessment); T2: Retest (follow-up assessment, 14–30 days after T1); r: Pearson correlation coefficient. Statistical significance was set at p < .05. All p-values in the table indicate statistically significant correlations (p < .001).
Item-level test and retest means, standard deviations, and test–retest correlations of the Niigata PPPD questionnaire (PPPD group).
Note. SD: Standard Deviation; r: Pearson correlation coefficient. Statistical significance was set at p < .05. All correlations were statistically significant (p < .001).
Fit indices for the NPQ (3-factor model).
Note. χ2/df: Chi-square to degrees of freedom ratio; CFI: Comparative Fit Index; TLI: Tucker-Lewis Index; NFI: Normed Fit Index; RMSEA: Root Mean Square Error of Approximation; PCLOSE: Probability of Close Fit.

CFA path diagram for the Turkish NPQ (T-NPQ) three-factor model. Rectangles represent the observed items (Q1–Q12) and ellipses represent latent factors (F1–F3). Small circles labeled e1–e12 denote item-specific error terms (residuals). Single-headed arrows from latent factors to items indicate factor loadings (standardized estimates displayed), and curved double-headed arrows between latent factors indicate factor associations (correlations/covariances). Numbers adjacent to error terms represent residual variances.
Pearson correlation coefficients between NPQ domains and DHI measures in differentiating PPPD from vestibular disorders (N = 76).
Note. NPQ: Niigata PPPD Questionnaire; DHI: Dizziness Handicap Inventory. * Correlation is significant at the 0.05 level (2-tailed). ** Correlation is significant at the 0.01 level (2-tailed).
ROC analysis for NPQ total and subscale scores in discriminating PPPD from other vestibular disorders.
Note. T-NPQ: Turkish version of the Niigata PPPD Questionnaire; PPPD: Persistent Postural-Perceptual Dizziness; ROC: Receiver Operating Characteristic; AUC: Area Under the Curve.
Discussion
This study represents the first successful translation, cultural adaptation, and psychometric validation of the T-NPQ. The principal finding confirms that the T-NPQ is a reliable and valid instrument for assessing symptom severity and characterizing the three main exacerbating factors of PPPD in Turkish-speaking patients. The need for a standardized, PPPD-specific tool is paramount, given that PPPD is one of the most common chronic neuro-otological conditions yet remains underdiagnosed due to the subjective nature of its symptoms and the absence of objective biomarkers.1,6
The internal consistency of the T-NPQ was found to be excellent, with a Cronbach’s alpha (α) coefficient of 0.919 for the total scale. This finding is highly consistent with the original Japanese validation (α > 0.90) 9 and the Spanish validation study which reported a similarly high internal consistency (α = 0.938). 5 These results across diverse languages suggest that the NPQ items measure a common underlying construct PPPD symptom severity consistently, regardless of cultural differences.
The internal consistency of the subscales was also acceptable to good (Upright Posture/Walking α = 0.762; Movement α = 0.749; Visual Stimulation α = 0.841). Notably, the Visual Stimulation subscale showed the highest α value. This aligns with recent epidemiological findings by Aishwarya et al. (2024), who reported that visual dominance was the primary exacerbating factor in a significant portion of the PPPD population in South India. 17 Furthermore, the test-retest reliability demonstrated strong temporal stability (Total NPQ correlation r = 0.832), confirming that the T-NPQ provides consistent scores when administered to clinically stable patients over time. This stability is crucial for monitoring treatment outcomes, as highlighted by Yagi et al. (2024), who emphasized the need for reliable metrics to track the often waxing and waning course of functional dizziness. 18
The psychometric evaluation of the T-NPQ’s underlying structure yielded findings that require careful interpretation within the context of existing literature. In the present study, construct validity was examined using CFA to test the hypothesized (a priori) three-factor model. CFA showed acceptable fit indices for the original three-factor structure (χ2/df = 1.47, RMSEA = 0.064, CFI = 0.964).
This result aligns with the theoretical framework of PPPD, which posits that symptoms are exacerbated by three distinct factors: upright posture, active/passive motion, and visual stimulation.2,9 Recent neuroimaging studies support this three-factor distinction; for instance, Yagi et al. (2023) demonstrated specific changes in functional connectivity between visual and vestibular cortices during visual stimulation tasks, providing a biological basis for the “Visual” subscale as a distinct symptom dimension. 19 Specifically, they found that visual inputs dominate over vestibular inputs in PPPD patients, altering the integration of spatial orientation.
In contrast, some Western validation studies have suggested a single-factor structure. 5 Our CFA findings supporting the three-factor model suggest that in the Turkish population, patients can distinctly identify and categorize their triggers. This distinction is clinically relevant because, as shown by Azami et al. (2023), different physiological subtypes may exist; they found that 44.2% of PPPD patients had isolated otolith dysfunction, which might differentially impact the “Upright Posture/Walking” or “Movement” subscales compared to patients with purely visual dominance. 20
The T-NPQ exhibited good discriminatory ability between the PPPD group and the “other vestibular disorder” group. The ROC curve analysis yielded an AUC of 0.746. This AUC value indicates good diagnostic accuracy and is higher than the AUC of 0.661 reported in the Spanish validation. 5
The calculated optimal cut-off score of 27.5 (Sensitivity: 86.1%, Specificity: 57.5%) is almost identical to the threshold of ≥27 points initially proposed by Yagi et al. 9 This consistency suggests that a total score of 28 or higher is a globally reproducible threshold for identifying patients with a high likelihood of PPPD. However, the relatively lower specificity (57.5%) warrants careful clinical interpretation. As recently highlighted by Sereda et al. (2025), patients with other chronic vestibular conditions, such as bilateral vestibulopathy, may also report high symptom burdens on the NPQ due to shared functional impairments, leading to potential false positives. 21 Therefore, the T-NPQ should not be used as a standalone diagnostic test but rather as a sensitive screening tool to quantify symptom severity and identify patients requiring further neuro-otological evaluation.
The Visual Stimulation subscale showed the highest individual AUC (0.674). This diagnostic utility is supported by Goto et al. (2025), who found that postural instability induced by moving visual stimuli (specifically checkerboard patterns) was significantly higher in PPPD patients compared to other vestibular disorders. 22 This reinforces “visual dependence” as a hallmark of the condition that the T-NPQ successfully captures.
The T-NPQ demonstrated strong concurrent validity through significant correlations with the DHI. 13 A moderate-to-strong positive correlation was observed between the NPQ Total score and the DHI Total score (r = 0.709, p < .001). The Visual Stimulation subscale showed the strongest correlation with the DHI Emotional subscale (r = 0.430, p < .001). This reinforces the complex interplay between sensory processing and psychological distress. Fukushima et al. (2024) recently highlighted age-related differences in this interplay; they found that younger PPPD patients exhibit significantly higher anxiety levels (HADS-A scores) compared to older patients, who are more likely to have peripheral vestibular precipitants. 23 This suggests that for younger patients with high scores on the Visual and Emotional domains, integrating cognitive behavioral therapy to address potential “perceived injustice” and anxiety mechanisms recently identified by Sereda et al. (2025) as mediators of symptom severity is crucial. 21 Conversely, older patients might benefit more from vestibular rehabilitation targeting otolith dysfunction. 20
Limitations
This study has several limitations that should be considered when interpreting the results.
First, the sample size (N = 114 overall; N = 36 in the PPPD group) is relatively small for conducting CFA. Nevertheless, this study should be viewed as a preliminary validation, and future studies with larger cohorts are recommended to further confirm the factor structure and to externally validate (cross-validate) the CFA model in independent samples. Future studies should also assess measurement invariance across diagnostic groups and sex/age strata.
Second, patients with significant psychiatric or cognitive comorbidities were excluded from the study. Although PPPD is known to frequently coexist with anxiety, depression, and other psychiatric disorders, this exclusion was intentional to ensure the validation of the T-NPQ in measuring specific vestibular symptoms (upright posture, motion, and visual stimuli) without the potential confounding effects of severe psychiatric symptoms.6,23 While this approach allowed for a cleaner assessment of the scale’s psychometric properties regarding physical symptoms, it limits the generalizability of the findings to the broader, “real-world” clinical population where comorbidities are common.
Third, although the DHI was used to assess dizziness-related handicap, specific psychological screening tools such as the Hospital Anxiety and Depression Scale (HADS) were not employed. Given recent findings identifying psychological variables like “perceived injustice” and anxiety as key mediators of PPPD symptom severity, the lack of direct psychological correlation analysis is a limitation. 21 However, the strong correlation observed between the NPQ and the DHI Emotional subscale in our study provides valuable initial insight into this relationship.
Fourth, the study relied on cross-sectional data, which limits our ability to assess the responsiveness of the T-NPQ to changes in symptoms over time. Longitudinal studies are needed to evaluate the T-NPQ’s sensitivity to change, particularly in response to therapeutic interventions or lifestyle modifications. This would be crucial for understanding its potential use in monitoring treatment efficacy and guiding clinical decision-making.
Finally, although the cultural context of the Turkish population was considered during the adaptation, cultural differences in symptom expression may still influence the results. Further validation studies in diverse cultural contexts are recommended to ensure the T-NPQ’s broad applicability.
Conclusion
The findings suggest that the Turkish version of the Niigata PPPD Questionnaire exhibits satisfactory psychometric properties. The results indicate a three-factor structure consistent with the original theoretical model and propose a cut-off score (≥28) that may be clinically useful. The T-NPQ appears to reflect the unique visual and motion-induced sensitivity of PPPD, aligning with recent insights into the disorder’s pathophysiology.19,22 Consequently, this instrument could facilitate standardized research and has the potential to contribute to the clinical management of this challenging disorder in Turkey.
Footnotes
Acknowledgments
We would like to express our sincere gratitude to Assistant Professor Chihiro Yagi for generously providing the Niigata PPPD questionnaire and for granting permission to translate it. We also wish to extend our heartfelt thanks to Buket Yüksek, Çiğdem Demir, Serenay Yoltaş, and Op. Dr Fuat Güder for their invaluable support and contributions throughout this research. Their guidance and encouragement have been truly instrumental in the completion of this work.
Ethical considerations
This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and approved on 01/08/2024 by the Non-Interventional Clinical Research Ethics Committee of Istanbul Medipol University (Approval No: 744).
Consent to participate
All participants were informed about the study purpose and procedures, and written informed consent was obtained prior to data collection.
Author contributions
Study concept and design: [Y.B., A.A.T.] Data collection: [Y.B. and A.A.T.] Analysis and interpretation of data: [Y.B. and H.B.S.] Drafting of the manuscript: [Y.B., A.A.T. and H.B.S.] Critical revision of the manuscript: [Y.B., A.A.T. and H.B.S.]
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Data Availability Statement
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
